Headlines about Welltower (NYSE:HCN) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Welltower earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave press coverage about the real estate investment trust an impact score of 46.6695386667787 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Here are some of the media headlines that may have effected Accern’s rankings:
- Welltower Announces Stock Ticker Change to “WELL” (markets.businessinsider.com)
- Welltower Inc (HCN) Stake Boosted by CORDA Investment Management LLC. (americanbankingnews.com)
- Martin Capital Partners LLC Purchases Shares of 35,585 Welltower Inc (HCN) (americanbankingnews.com)
- Welltower: Buyers Will Eventually Step In – Welltower Inc. (NYSE … – Seeking Alpha (seekingalpha.com)
- How Healthcare Trust of America Rewards Its Investors (finance.yahoo.com)
Shares of Welltower (HCN) traded down $2.18 during midday trading on Wednesday, hitting $52.22. 3,189,636 shares of the stock were exchanged, compared to its average volume of 2,960,813. The firm has a market cap of $19,470.00, a P/E ratio of 20.89, a P/E/G ratio of 3.96 and a beta of 0.17. Welltower has a 1 year low of $52.22 and a 1 year high of $78.17. The company has a quick ratio of 1.76, a current ratio of 1.85 and a debt-to-equity ratio of 0.83.
The company also recently declared a quarterly dividend, which was paid on Wednesday, February 21st. Stockholders of record on Tuesday, February 13th were given a $0.87 dividend. The ex-dividend date of this dividend was Monday, February 12th. This represents a $3.48 dividend on an annualized basis and a dividend yield of 6.66%. Welltower’s dividend payout ratio (DPR) is currently 139.20%.
A number of research firms have weighed in on HCN. BMO Capital Markets reissued a “sell” rating and set a $57.00 target price on shares of Welltower in a report on Thursday, February 22nd. Zacks Investment Research raised shares of Welltower from a “sell” rating to a “hold” rating in a report on Tuesday, January 23rd. Citigroup reduced their target price on shares of Welltower from $67.00 to $54.00 and set a “neutral” rating on the stock in a report on Tuesday. Mizuho reissued a “hold” rating and set a $67.00 target price on shares of Welltower in a report on Monday, December 11th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $60.00 target price (down from $74.00) on shares of Welltower in a report on Friday, February 23rd. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $67.29.
In other news, Director Gary Whitelaw purchased 1,862 shares of the company’s stock in a transaction dated Monday, February 26th. The shares were purchased at an average price of $53.61 per share, for a total transaction of $99,821.82. Following the transaction, the director now owns 5,843 shares of the company’s stock, valued at $313,243.23. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.19% of the stock is currently owned by insiders.
Welltower Company Profile
Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.